NEW YORK (AP) -- Eye care product maker The Cooper Cos. said Tuesday that it has addressed problems that led to a warning letter from regulators in December.
The Food and Drug Administration sent Cooper a warning letter after inspecting its U.S. distribution center in New York. Cooper said the FDA cited problems related to labeling and packaging and said it was working to resolve those problems. The company said Tuesday that the FDA has reviewed its corrective actions and that the agency believes the problems have been addressed.
Cooper received the letter from the FDA on Thursday and disclosed it in a form filed with the Securities and Exchange Commission on Tuesday.
Cooper shares fell 57 cents to close at $76.70.
